Emerging Infectious Diseases (May 2021)

Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand

  • Jemma L. Geoghegan,
  • Jordan Douglas,
  • Xiaoyun Ren,
  • Matthew Storey,
  • James Hadfield,
  • Olin K. Silander,
  • Nikki E. Freed,
  • Lauren Jelley,
  • Sarah Jefferies,
  • Jillian Sherwood,
  • Shevaun Paine,
  • Sue Huang,
  • Andrew Sporle,
  • Michael G. Baker,
  • David R. Murdoch,
  • Alexei J. Drummond,
  • David Welch,
  • Colin R. Simpson,
  • Nigel French,
  • Edward C. Holmes,
  • Joep de Ligt

DOI
https://doi.org/10.3201/eid2705.204579
Journal volume & issue
Vol. 27, no. 5
pp. 1317 – 1322

Abstract

Read online

Real-time genomic sequencing has played a major role in tracking the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), contributing greatly to disease mitigation strategies. In August 2020, after having eliminated the virus, New Zealand experienced a second outbreak. During that outbreak, New Zealand used genomic sequencing in a primary role, leading to a second elimination of the virus. We generated genomes from 78% of the laboratory-confirmed samples of SARS-CoV-2 from the second outbreak and compared them with the available global genomic data. Genomic sequencing rapidly identified that virus causing the second outbreak in New Zealand belonged to a single cluster, thus resulting from a single introduction. However, successful identification of the origin of this outbreak was impeded by substantial biases and gaps in global sequencing data. Access to a broader and more heterogenous sample of global genomic data would strengthen efforts to locate the source of any new outbreaks.

Keywords